Veracyte, Inc. (NASDAQ:VCYT) Q1 2025 Earnings Call May 7, 2025 4:30 PM ET
Company Participants
Shayla Gorman – Investor Relations
Marc Stapley – Chief Executive Officer
Rebecca Chambers – Chief Financial Officer
John Leite – Chief Commercial Officer
Conference Call Participants
Subbu Nambi – Guggenheim Securities
Andrew Brackmann – William Blair
Puneet Souda – Leerink Partners
Colleen Babington – Wolfe Research
Tejas Savant – Morgan Stanley
Thomas DeBourcy – Nephron Research
Sung Ji Nam – Scotiabank
Operator
Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2025 Financial Results Webcast. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Shayla Gorman, Senior Director, Investor Relations. Please go ahead.
Shayla Gorman
Good afternoon, everyone and thank you for joining us today for a discussion of our first quarter 2025 financial results. With me today are Marc Stapley, Veracyte’s Chief Executive Officer; Rebecca Chambers, our Chief Financial Officer; and John Leite, our Chief Commercial Officer, who will join us for Q&A. Veracyte issued a press release earlier this afternoon detailing our first quarter 2025 financial results. This release and a copy of the presentation we will review during the call today are available in the Investors section of our website at veracyte.com.
Before we begin, I’d like to remind you that statements we make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties, and the company can give no assurance they will prove to be correct. Additionally, we are not under any obligation to provide further updates on our business trends or our performance during the quarter. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the
#Veracyte #VCYT #Earnings #Call #Transcript